Latest filing: Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On August 01, 2026
ObservedCompany dossier
Orchid Pharma
NSE:ORCHPHARMA · ISIN INE191A01027
- Close
- ₹1,001.45 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Orchid Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹217.3 Cr · PAT ₹20.8 Cr.
Exchange XBRLLatest ownership: promoter group 69.84% and public 30.16% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Orchid Pharma Limited
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On August 01, 2026
BSE · exchange filing
Observed
Source filing Orchid Pharma Ltd - 524372 - Intimation Regarding Investor Roadshow
BSE · exchange filing
Observed
Source filing Updates - Orchid Pharma Limited
NSE · exchange filing
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Orchid Pharma Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹217.3 Cr
- Profit after tax
- ₹20.8 Cr
- EPS
- ₹4.10
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 69.84%
- Public
- 30.16%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL